We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Both officials from the UN and French-based pressure group Medecins Sans Frontiéres have expressed concerns about the impact that a proposed free trade agreement (FTA) between the US and Andean countries could have on drug access for patients in Peru.
Millenia Hope Inc., a Delaware Biopharma corporation (OTC Bulletin Board: MLHP; Berlin: MLF), today announced that it has sold 10,000 treatments of MMH Malarex(TM)/MMH 18(TM) to a private clinic in Mali.
Health-care products maker Abbott Laboratories Inc. said Monday that it received expanded European approval for the rheumatoid arthritis drug Humira to treat earlier forms of the disease and to treat psoriatic arthritis.
Allon Therapeutics Inc. (TSX-V: "NPC"), The Neuro Protection Company(TM), announced today that it has arranged a $6.2-million private placement of common shares to a group of largely institutional investors at a price of $1.05 per share.
Cita NeuroPharmaceuticals Inc. on Monday said it is in "advanced discussions" to be acquired by an international pharmaceutical company, prompting Cita to delay its initial public offering.
A new multimillion-dollar primary healthcare centre has been opened
in Al Naema in the United Arab Emirates (UAE), the first of 18 new primary healthcare centres planned for the region.